Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French Medtechs Demand Attention To Ongoing Reimbursement Delays

Executive Summary

French medtech manufacturers are expecting positive results from recent ministerial efforts to make the national health-care products reimbursement agency, the CEPS, speed up its current slow handling of applications for products and services to enter commercial use in France's public-health system.

You may also be interested in...



French Medtechs Blast 'Double Whammy' Of Price Cuts, New-Product Stalemate

Eric Le Roy, chief executive of the French medical technology industry association SNITEM, is angry about the national reimbursement authority's failure to get to grips with staffing shortages holding up price-setting for new technologies, and its current preoccupation with medtech pricing cuts. "Enough is enough," he said in an interview.

When Will POC Really Be On The Cusp Of Major Uptake?

Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data via automation and IT means that progress might change at last. How the tests are paid for remains an issue. The future of POC was the theme of an investor discussion at the first DxPx conference, held during the Medica 2019 event in Germany.

EU MDR Must Ensure Medtech Innovation Keeps Flowing, Say German MPs

For many, the EU MDR is coming too fast, yet several of its crucial elements are not yet in place. Germany’s liberal FDP MPs say the national government needs to make a stand and address a European issue that will impact German patients. In a motion to parliament, the MPs propose fast-tracking for innovative products and measures to keep orphan devices in circulation.

Topics

UsernamePublicRestriction

Register

MT103973

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel